Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles

被引:226
作者
Chalasani, Kishore B.
Russell-Jones, Gregory J.
Jain, Akhlesh K.
Diwan, Prakash V.
Jain, Sanjay K.
机构
[1] Indian Inst Chem Technol, Div Pharmacol, Hyderabad 500007, Andhra Pradesh, India
[2] Dept Pharmaceut Sci, Nagpur 470003, Maharashtra, India
关键词
oral insulin; cross-linking; vitamin B-12; nanoparticle conjugates; diabetes;
D O I
10.1016/j.jconrel.2007.05.019
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
The potential utility of vitamin B12 carrier system for the oral delivery of conjugated peptides/proteins and enhancement of nanoparticles (NPs) transport has been demonstrated. The present study aims to optimize the effectiveness of VB12-NPs conjugates using different levels of cross-linking, linked with different VB12-COatings and evaluates in animal models to investigate an efficient insulin carrier. Amino alkyl VB12 derivatives suitable for oral delivery were synthesized at 5 ' hydoxy ribose and c-propionamide sites via carbamate and ester/amide linkages, and were coupled to succinic acid modified dextran NPs of varied cross-linking. VB12 binding was confirmed by XPS analysis, and was quantified by HPLC (4.0 to 5.7% w/w of NPs). These polydisperse NPs conjugates showed higher size, high insulin entrapment and faster insulin release with low levels of cross-linking. These VB12-NPs conjugates (150-300 nm) showed profound (70-75% blood glucose reductions) and prolonged (54 h) anti-diabetic effects with biphasic behaviour in STZ diabetic rats. NPs with the low levels of cross-linking were found to be superior carriers, and were more effective with VB12 derivatives of carbamate linkage. The pharmacological availability relative to SC insulin was found to be 29.4%, which was superior compared to NPs conjugate of ester linked VB12 (1.5 fold) and relatively higher cross-linked particles (I. I fold). Further, the NPs carrier demonstrated a similar oral insulin efficacy in congenital diabetic mice (60% reduction at 20 h). Significant quantities of plasma insulin were found in both animal models (231 and 197 mu IU/ml). At two investigated doses, the carrier system shows dose response. Pre-dosing with a large excess of free VB12 minimized the observed activity, indicating predominance of VB12 mediated uptake. It is concluded that VB12-dextran NPs conjugate is a viable carrier for peroral insulin delivery to treat diabetics. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 48 条
[1]
C-13 NUCLEAR MAGNETIC-RESONANCE STUDIES OF THE MONOCARBOXYLIC ACIDS OF CYANOCOBALAMIN - ASSIGNMENTS OF THE B-MONOCARBOXYLIC, D-MONOCARBOXYLIC, AND E-MONOCARBOXYLIC ACIDS [J].
ANTON, DL ;
HOGENKAMP, HPC ;
WALKER, TE ;
MATWIYOFF, NA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1980, 102 (07) :2215-2219
[2]
Nanosphere based oral insulin delivery [J].
Carino, GP ;
Jacob, JS ;
Mathiowitz, E .
JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) :261-269
[3]
INTENSIVE INSULIN THERAPY AND WEIGHT-GAIN IN IDDM [J].
CARLSON, MG ;
CAMPBELL, PJ .
DIABETES, 1993, 42 (12) :1700-1707
[4]
A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin [J].
Chalasani, Kishore B. ;
Russell-Jones, G. J. ;
Yandrapu, Sarath K. ;
Diwan, Prakash V. ;
Jain, Sanjay K. .
JOURNAL OF CONTROLLED RELEASE, 2007, 117 (03) :421-429
[5]
Oral particulate delivery: status and future trends [J].
Chen, HM ;
Langer, R .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) :339-350
[6]
Self-assembled "nanocubicle" as a carrier for peroral insulin delivery [J].
Chung, H ;
Kim, J ;
Um, JY ;
Kwon, IC ;
Jeong, SY .
DIABETOLOGIA, 2002, 45 (03) :448-451
[7]
Council of Scientific and Industrial Research, 2002, [No title captured], Patent No. [6482413, US6482413]
[8]
Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation [J].
Cui, Fude ;
Shi, Kai ;
Zhang, Liqiang ;
Tao, Anjin ;
Kawashima, Yoshiaki .
JOURNAL OF CONTROLLED RELEASE, 2006, 114 (02) :242-250
[9]
NEW APPROACH FOR ORAL-ADMINISTRATION OF INSULIN WITH POLYALKYLCYANOACRYLATE NANOCAPSULES AS DRUG CARRIER [J].
DAMGE, C ;
MICHEL, C ;
APRAHAMIAN, M ;
COUVREUR, P .
DIABETES, 1988, 37 (02) :246-251
[10]
Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model [J].
Fasano, A ;
Uzzau, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1158-1164